| Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B MF Yuen, Y Tanaka, DYT Fong, J Fung, DKH Wong, JCH Yuen, DYK But, ... Journal of hepatology 50 (1), 80-88, 2009 | 671 | 2009 |
| HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma MF Yuen, DKH Wong, J Fung, P Ip, D But, I Hung, K Lau, JCH Yuen, ... Gastroenterology 135 (4), 1192-1199, 2008 | 453 | 2008 |
| Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study WK Seto, TSY Chan, YY Hwang, DKH Wong, J Fung, KSH Liu, H Gill, ... Journal of Clinical Oncology 32 (33), 3736-3743, 2014 | 351 | 2014 |
| Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease MF Yuen, WK Seto, DHF Chow, K Tsui, DKH Wong, VWS Ngai, ... Antiviral therapy 12 (8), 1295-1304, 2007 | 332 | 2007 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 307 | 2022 |
| Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma KKC Ng, KSH Chok, ACY Chan, TT Cheung, TCL Wong, JYY Fung, ... Journal of British Surgery 104 (13), 1775-1784, 2017 | 285 | 2017 |
| Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B J Fung, CL Lai, WK Seto, MF Yuen Journal of antimicrobial chemotherapy 66 (12), 2715-2725, 2011 | 271 | 2011 |
| Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection IFN Hung, RTP Poon, CL Lai, J Fung, ST Fan, MF Yuen Official journal of the American College of Gastroenterology| ACG 103 (7 …, 2008 | 259 | 2008 |
| Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation J Fung, C Cheung, SC Chan, MF Yuen, KSH Chok, W Sharr, WC Dai, ... Gastroenterology 141 (4), 1212-1219, 2011 | 235 | 2011 |
| Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection DKH Wong, Y Tanaka, CL Lai, M Mizokami, J Fung, MF Yuen Journal of clinical microbiology 45 (12), 3942-3947, 2007 | 216 | 2007 |
| Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels MF Yuen, Y Tanaka, N Shinkai, RT Poon, DYK But, DYT Fong, J Fung, ... Gut 57 (1), 98-102, 2008 | 213 | 2008 |
| Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5‐year ideal response MF Yuen, DYT Fong, DKH Wong, JCH Yuen, J Fung, CL Lai Hepatology 46 (6), 1695-1703, 2007 | 211 | 2007 |
| Three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety MF Yuen, WK Seto, J Fung, DKH Wong, JCH Yuen, CL Lai Official journal of the American College of Gastroenterology| ACG 106 (7 …, 2011 | 203 | 2011 |
| Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ... Gastroenterology 156 (3), 635-646. e9, 2019 | 199 | 2019 |
| Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA DKH Wong, WK Seto, KS Cheung, CK Chong, FY Huang, J Fung, CL Lai, ... Liver International 37 (7), 995-1001, 2017 | 195 | 2017 |
| Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma DKH Wong, FY Huang, CL Lai, RTP Poon, WK Seto, J Fung, IFN Hung, ... Hepatology 54 (3), 829-836, 2011 | 193 | 2011 |
| Hepatitis B and C virus-related carcinogenesis J Fung, CL Lai, MF Yuen Clinical Microbiology and Infection 15 (11), 964-970, 2009 | 191 | 2009 |
| Reduction of covalently closed circular DNA with long-term nucleos (t) ide analogue treatment in chronic hepatitis B CL Lai, D Wong, P Ip, M Kopaniszen, WK Seto, J Fung, FY Huang, B Lee, ... Journal of hepatology 66 (2), 275-281, 2017 | 189 | 2017 |
| Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B WK Seto, DKH Wong, J Fung, FY Huang, KSH Liu, CL Lai, MF Yuen Clinical Microbiology and Infection 20 (11), 1173-1180, 2014 | 165 | 2014 |
| Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos (t) ide analogues of different potency DKH Wong, WK Seto, J Fung, P Ip, FY Huang, CL Lai, MF Yuen Clinical gastroenterology and hepatology 11 (8), 1004-1010. e1, 2013 | 157 | 2013 |
